Page 1

PERPETUA MEDICAL INTERIM REPORT JANUARY - JUNE 2026 Continued growth Reporting period April - June 2026 • • The Group reported net revenue of 5,963 ( 2,700 ) KSEK for the second quarter . Operating loss for the second quarter amounted to -3,095 ( -538 ) KSEK . • Earnings per share , both basic and diluted , were - 0.36 ( -0.16 ) SEK for the period . • Cash flow for the second quarter amounted to -3,456 ( -1,224 ) KSEK , and cash and cash equivalents totaled 16,828 ( 5,989 ) KSEK at the end of the quarter . Reporting Period January - June 2026 • • For the first half - year , the Group's net sales amounted to 10,943 ( 5,927 ) KSEK . Operating profit for the first half - year amounted to -5,861 ( -1,972 ) KSEK . • Earnings per share , basic and diluted , were -0.69 ( -0.44 ) SEK for the period . • Cash flow for the first half - year amounted to 12,495 ( -3,411 ) KSEK , and cash and cash equivalents totaled 16,826 ( 5,989 ) KSEK at the end of the quarter . Comparative figures in parentheses refer to the corresponding period of the previous year , unless otherwise stated . Events During the Reporting period April - June 2026 • • • Perpetua Medical AB expanded its management team by appointing Thomas Pousette , an experienced corporate lawyer with many years in the medical technology sector . The Annual General Meeting of Perpetua Medical AB was held on 29 May 2026. The meeting resolved all proposed agenda items in accordance with the Board's recommendations , as presented in the notice convening the meeting . At the Annual General Meeting , a new Board member , Olof Stranding , was elected . Wilhelm Risberg stepped down from the Board . Perpetua Medical AB ( publ ) Interim report , reporting period January - June 2026 1 ( 18 )